Interested parties may access the live call via telephone by dialing (800) 715-9871 for domestic callers or (646) 307-1963 for international callers, using...
“2022 was a momentous year for HilleVax where the company achieved many important milestones including the initiation and execution of our Phase 2b c...
Following the press release, the Company management will host a conference call on Friday, March 24th 2023 at 1 p.m. CET / 8 a.m. ET to discuss full year 2...
A news release will be issued at approximately 6:30 a.m. Eastern Time (ET) and will be available at www.bd.com/investors, along with related...
© 2025 Biopharma Boardroom. All Rights Reserved.
